Essays on Adjuvant

Literature review

Kaasa, S. (2015). Is Cancer Pain Control Improved by a Simple WHO Pain Analgesic Ladder Approach Combined With Tumor-Directed Treatment?.Journal of Clinical Oncology, JCO647537.

Article summary

This article takes into consideration the role that the WHO analgesic ladder plays in addressing cancer pain in palliative care patients. The authors identify that cancer pain occurs in 90% of cancer patients but only half them are under proper pain management. To this effect, therefore, there is the need for applying opioids under the WHO ladder guidelines as a way of addressing cancer pain in oncology care patients.

This is a narrative qualitative research ...

Juvaris BioTherapeutics   

Today in the world we have many new forms of diseases. Cancer is the most dangerous and insidious scourge. To treat cancer we should spend plenty of time and money and there is a great field of work. Juvaris BioTherapeutics, Inc. is a company, located in Pleasanton, California, which develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer and helps both human and animals. Company was registered in 2001 with total amount of employees approximately 50 persons. It provides JVRS-100, a cationic lipid-DNA complex and adjuvant that improves the efficiency of present vaccines, as well as ...

Brief information, risk factors and symptoms

Colon cancer, that is also known as colorectal, is a type of cancer that starts from rectum or colon. As any other type of cancer, colon cancer is characterized by uncontrolled growing cells of the body. This type of cancer usually starts with a polyp – a kind of growth on the inner lining of the rectum or colon. However, it is important to know that not all polyps change into cancer, though some of them might do it after several years. The chances that a polyp will become cancer after some, depends on the type of polyps. There are ...